Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical Study

Ain Shams University

Status and phase: Not yet enrolling; Phase 2; Phase 1

Conditions: Androgenetic Alopecia

Treatments: Drug: Plasma derived exosomes

Study type: Interventional

Funder types: Other

Identifiers

NCT07112586

Fmasu MD 12 20242025

Details and patient eligibility

About

Intradermal injection of exosomes in treatment of male androgenetic alopecia, clinically and using a immunohistochemical marker

Enrollment: 15 estimated patients

Sex: Male

Ages: 18 to 40 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Androgenetic Alopecia Grades 1-4

Exclusion criteria

• blood diseases Receiving other treatments History of malignancy or allergic reaction to exosomes

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

15 participants in 1 patient group

Males 18-40 years old with androgenetic alopecia

Experimental group

Description:

Males with androgenetic alopecia willing to do mesotherapy sessions

Treatment:

Drug: Plasma derived exosomes